Get Real Time Here
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Ocuphire Pharma Stock (NASDAQ:OCUP), Quotes and News Summary
Ocuphire Pharma Stock (NASDAQ: OCUP) stock price, news, charts, stock research, profile.
| Open3.520 | Close3.350 |
| Vol / Avg.768.088K / 210.509K | Mkt Cap73.040M |
| Day Range3.090 - 3.558 | 52 Wk Range1.960 - 6.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.230 | -0.240 | -0.0100 | ||||
| REV | 2.420M | 3.674M | 1.254M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 17.00 |
| 2023-08-14 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-05-16 | HC Wainwright & Co. | Matthew Caufield | Reiterates | BuyBuy | Maintains | - | 20.00 |
| 2023-03-31 | HC Wainwright & Co. | Matthew Caufield | Reiterates | Buy | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy Ocuphire Pharma (OCUP) stock?
You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.
Who are Ocuphire Pharma's (OCUP) competitors?
Other companies in Ocuphire Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for Ocuphire Pharma (OCUP) stock?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Cantor Fitzgerald on Monday, August 14, 2023. The analyst firm set a price target for 17.00 expecting OCUP to rise to within 12 months (a possible 394.19% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Ocuphire Pharma (OCUP)?
The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $3.44 last updated September 29, 2023 at 9:55 PM UTC.
Does Ocuphire Pharma (OCUP) pay a dividend?
There is no dividend information for Ocuphire Pharma.
When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?
Ocuphire Pharma’s Q3 earnings are confirmed for Friday, November 3, 2023.
Is Ocuphire Pharma (OCUP) going to split?
There is no upcoming split for Ocuphire Pharma.
What sector and industry does Ocuphire Pharma (OCUP) operate in?
Ocuphire Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.